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The study objective was to investigate patient experienced error during diagnosis and treatment of cancer.
included a nationwide patient survey on quality and safety in Danish cancer care. Responses regarding patient 
experienced error were separately analyzed, quan
using systematic text analysis. Study participants included
registered between May 1st and August 31st 2010
care received by general practitioners, specialist 
10 – 25% of patients experienced error during diagnosis or treat
consequences. Unexpected surgical errors/complications (27%), delay due to doctors’ assessment errors (24%) and 
unavailable test results (21%) were the most frequent types of errors identified using closed questions. 819 qua
responses supplemented this information and revealed errors related to cancer detection, planning & coordination, 
patient-provider communication, administrative processes and treatment & medication. Physical, psychological, social as 
well as organizational consequences of the errors were uncovered.
related to informed consent, diagnostic reasoning as well as handling of test results, referrals and the medical chart 
should be further improved. In addition, safety aspects of the patient
patients as an extra safety barrier merit further study.
 
Keywords 






Cancer patients are at risk of being harmed during their 
contact with health care services.1 The disease itself 
introduces infirmity, but treatment and delivery of care can 
also pose risks to patients. In Denmark, various providers 
in complex patient journeys deliver cancer care
general practitioner (GP) as a gatekeeper to specialist 
practitioners outside of hospitals as well as to specialist 
care at hospitals. 
 
Previous studies on safety and quality in cancer care show 
that both general risks and risks specific to cancer 
treatment occur frequently.1-3 Gathering information from 
various sources is necessary to complete the understanding 
of hazards.4-5 Usually, safety is assessed from a health care 
perspective and the patients’ experiences of errors have 
only been explored to a limited extent. However, inclusion 
of patients’ experiences of errors is relevant when mapping 
safety problems.6 As the patient is the only person 
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titative responses using descriptive statistics and qualitative responses 
 6,720 adult patients with a first time diagnosis of cancer 
. The patients received a questionnaire concerning their experiences of 
practitioners and at the hospital. A response rate of 65% was achieved. 
ment.  61% reported that hospital errors had 
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-provider communication and involvement of 
 
, with the 
experiencing the entire journey, patients can supplement 
existing knowledge of safety problems in health care.
 
In 2004, due to an act on Patient Safety, reporting of 
adverse events to the Danish Patient Safety Database 
became mandatory for health care professionals. The aim 
was to support learning and enhance patient safety.
Disclosure to patients is not mandato
reporting system, but according to the act on patients’ 
rights patients should be informed about the consequences 
of any errors.   
 
The aim of this study is to examine patient experienced 
error related to diagnosis and treatment of ca
Danish health care sector based on a survey conducted by 
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Method 
 
This nationwide survey was based on a population of 
8.607 cancer patients in Denmark aged 18 years and above 
registered in the National Patient Registry with a first time 
cancer diagnosis between May 1st and August 31st 2010. 
Exclusion criteria were death, emigration, unknown 
address, research protection, misdiagnosis, a suspected 
cancer, basal cell carcinoma, and benign or unspecified 
tumors. A total of 6.720 patients were included. A 
questionnaire addressing quality and safety in cancer care 
was mailed to patients in September and October 2010 . 
The questionnaire had 104 items. Five items addressed 
patient experienced error and consequences (Q15, Q19, 
Q26, Q56, Q57: see table 2-4) and one item collected 
‘other comments’ (general comments on the last page). 
Error questions were partly closed, partly open-ended. The 
closed questions were drafted based on previous studies.1 
They were posed to quantify ‘known’ types of errors, that 
is the experience of error at various providers in relation to 
diagnostics and treatment respectively along with the 
experience of consequences. A cognitive validation of the 
questionnaire revealed that patients understood the term 
error and used it to describe rather serious problems, 
whereas minor problems in general were not considered 
errors. Thus, the word ‘error’ was used in the 
questionnaire rather than e.g. ‘safety problem’ and ‘adverse 
event’ because it is a word used in everyday spoken 
Danish. Closed questions were supplemented by open-
ended questions in order to qualify both types of errors 
and types of consequences. Safety information from the 
item ‘general comments’ section was identified and 
included in the analysis.  
 
Two separate analyses were conducted: 1) quantitative 
analysis of the closed questions and 2) qualitative analysis 
of the open-ended questions. 
 
In the quantitative analysis data from the closed questions 
were summarized using descriptive statistics (PASW 
statistics 18®). 
 
The qualitative analyses of open questions were conducted 
to identify categories of patient experienced errors and 
consequences respectively (figure 1).  The patients’ 
descriptions were typed into a database and analyzed in the 
following steps using Malterud’s systematic text 
condensation:11 
1. All responses were read in order to provide an 
overview. Unreadable responses and responses with 
no relation to patient safety were excluded. 
2. Elements concerning patient experienced error and 
consequences of error were identified. The errors 
were organized according to provider and to 
diagnostics/treatment: GP during diagnosis, specialist 
practitioners during diagnosis, hospital during 
diagnosis, hospital during treatment. Consequences of 
error were analyzed separately. Key points were 
extracted and categories of types of errors and 
consequences were created. New categories were 
created until no more categories emerged. The 
smallest categories were collapsed into meta-
categories to reduce complexity. 
3. All responses were deductively coded according to the 
created categories. Comments that covered multiple 
errors or consequences were coded in the relevant 
number of categories. Errors described in the general 
comments section were grouped with the relevant 
error items and included in the analysis. 
4. The content of the identified categories was 
summarized and described. By keeping content 
descriptions against the original responses, data was 
re-contextualized in order to ensure that content 
descriptions were loyal to the patients’ experiences. 
Quotes that described the categories were selected. 





A total of 4.346 patients returned the questionnaire 
(response rate 65%). Mean age of respondents was 65 
years (19-96 years). Men and women were equally 
represented in the respondent group (49% vs. 51%). The 
most frequent cancer diagnoses were breast (23%), 
gastrointestinal (19%), prostate (17%) and lung (8%). 
When comparing respondents and non-respondents it 
appeared that the proportion of women and younger 
patients was slightly higher among respondents and that 
the proportion of patients living alone was lower among 
respondents. The lowest participation rates were observed 
for patients with ‘lung cancer’ and ‘gastrointestinal cancer 
besides colon and rectum’. Breast cancer patients had the 
highest participation rate (Table 1). 
 
Quantitative Analysis 
During diagnostics 10% of the respondents experienced 
error at their GP, 11% at the specialist practitioner and 
15% at the hospital. During hospital treatment 25% 
experienced error, with 61% reporting that the error had 
consequences (table 2). The frequencies of types of errors 
are shown in table 3 (diagnostics) and table 4 (treatment). 
Since some patients chose not to respond to all the 
relevant questions, sample sizes vary across items. Thus, in 
the tables below the number of responses (sample sizes) 
are specified for every single question.  
 
Qualitative Analysis 
919 respondents answered one or more of the open-ended 
questions. Only responses concerning patient safety were 
included in the analysis, thus the text condensation 
comprised 752 responses. 67 error descriptions were 
identified in the general comments section thus 819 
responses were included in the qualitative analyses. 
Patient experienced error, Lipczak et al.  
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Text condensation led to the formation of six categories of 
types of errors and five categories of consequences of 
errors (figure 1). The following sections present data from 
each of the type of error categories. Within each category, 
data is organized according to provider and 
diagnostics/treatment.  The nature of errors are described, 
listed by occurrence in the material (the most frequent 
first) and followed by quotes for illustration.  
 
Cancer Detection 
At the GP, patients experienced inadequate examination 
of symptoms e.g. patients contacted the doctor repeatedly 
before referral to further examination (‘My GP thought that I 
was obstipated. I suffered from bowel symptoms for about three years 
before I was referred to a specialist practitioner’). A substantial 
number of patients were diagnosed with other diseases 
than cancer or treated for something else before cancer 
diagnostics were initiated (‘I went to see the GP in January 
2009 because of tiredness. The GP thought I suffered from vitamin 
deficiency. In July 2009, I experienced joint pain, which the GP 
thought was arthritis. In January 2010, my lymph nodes were 
swollen which eventually led to my cancer being diagnosed’). At the 
specialist practitioner, patients experienced examinations 
that did not reveal the cancer, signs or symptoms that were 
overlooked or situations where the patient was believed to 
have another disease (‘I had my colon examined in February 
2009 – everything was OK. According to the operating surgeon, a 
tumor cannot grow to this size in two years and two months. Another 
doctor said the same – he said: it has been overlooked’). At the 
hospital, patients reported false negative test results (‘I had 
both mammography and ultrasound in October 2007 and was told 
that there was no tumor. When I was examined again in June, I was 
told that the tumor was already present in 2007’). Also, repetition 
of tests and insufficient examination were experienced 
(‘Bone scan pictures were of low quality. The doctor could not read 
the pictures properly, so the scan was repeated one week later’). 
 
Planning & Coordination 
At the GP, delay was frequently reported and often 
described as waiting time for medical examination – 
sometimes related to vacation and sick leave among 
doctors (‘I was to get the test results from the biopsy, but my GP 
had taken a vacation for 6 weeks. The answer was postponed and 
later I was acute hospitalized’). At the specialist practitioner 
waiting for medical examination was also frequently 
experienced. At the hospital during diagnosis, delay was 
the dominant problem and took different forms, e.g. the 
patient had to wait for examinations, tests, results or 
diagnosis. During treatment at hospital delay was often 
described as being derived from clinical or administrative 
processes (‘The antibody treatment was forgotten. It was started up 
three weeks later than first planned’). 
 
Patient-provider Communication 
At the GP, patients stated that they were not taken 
seriously when they consulted their GP (‘The GP would not 
listen and didn’t take my symptoms seriously’). Others described 
that they were ‘dismissed’ or falsely reassured that their 
symptoms were not signs of serious illness (‘The GP 
wouldn’t admit me to hospital even though the paralysis spread from 
Figure 1. Categories of patient experienced errors and consequences 
Described error at GP (Q15)
Described error at specialist 
(Q19)
Described error at hospital 
(pre diagnosis) (Q26)
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left to right arm and leg and I couldn’t control gas or stool’). At the 
specialist practitioner, patients experienced the 
communication to be insufficient, unclear or containing 
contradictory information (‘the dermatologist looked at the skin 
spot with a dermatoscope and said ‘it is nothing, but have a plastic 
surgeon remove it so it will look better than if I do it’. She did not 
leave me with the impression that I should hurry to make an 
appointment’). At the hospital during diagnosis, the 
communication often was presented as ‘poor’ e.g. having 
the diagnosis delivered over the phone, language 
problems, lack of empathy and insufficient preparation for 
bad news. At hospital during treatment, many patients 
described lack of information and contradictory 
information (‘at the first consultation I was told to stop taking a 
certain kind of pills. At the next I was told that I should take the 
pills and that the first instruction was a misinformation’).  
 
Administrative Processes 
At the GP, patients described referrals that were not sent 
or received as expected (‘the first electronic referral from my GP 
was never received at the hospital. It was discovered when I contacted 
my GP’). At the specialist practitioner, errors primarily 
related to test results that were overlooked, delayed, not 
sent or received as expected (‘the hospital never received the test 
results the medical specialist said he would send’). During 
diagnosis at the hospital, errors related to handling of 
test results (results not seen, not analyzed, delayed or 
unavailable) and to the medical chart (‘I was referred from 
Hospital X to Hospital Y. My medical chart was sent from X to Y 
but when I was referred back, they forget to send my chart to X. This 
was discovered when I contacted Hospital Y’). During treatment 
at the hospital, patients experienced error related to test 
results (unavailable, not read, unknown, delayed, lost) and 
the medical chart (e.g. missing chart, wrong information) 
Table 1. Patient characteristics by response status 
 
Variable Respondents Non-respondents Test 
 N % n % p-value 
Total 4,346 65 2,374 35 n/a 
Gender 
Male 2,138 49 1,323 56 
<0,001 
Female 2,208 51 1,051 44 
Cancer diagnosis 
Breast 982 23 267 11 
<0,001 
Prostate 720 17 352 15 
Colon 394 9 207 9 
Rectum 218 5 95 4 
Lung 363 8 323 14 
Malignant melanoma 228 6 129 5 
Uterus 108 3 51 2 
Head and Neck 205 5 117 5 
Gastrointestinal, other than colon and rectum 203 5 204 9 
Female genital organs 123 3 72 3 
Urinary tract 204 5 123 5 
Lymphoid, hematopoietic and related tissue 283 7 186 8 
Other 305 7 248 11 
Age groups 
18-39 132 3 95 4 
<0,001 
40-49 302 7 140 6 
50-59 767 18 368 16 
60-69 1,520 35 636 27 
70-79 1,099 25 630 27 
80-89 485 11 438 19 
90+ 41 1 67 3 
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(‘The test result revealing if the cancer had been removed was not 
available when I met at the hospital 14 days after discharge to receive 
the result’).  
 
Treatment & Medication Processes  
At the hospital during diagnosis and treatment 
patients experienced errors related to surgical/invasive 
procedures especially biopsies (unusable sample, 
complications, lost sample) (‘Due to bleeding the biopsy material 
couldn’t be used’). In addition, imaging errors were frequently 
described (inadequate preparation, not performed, 
repeated or poor quality images) (‘When I was referred to a 
PET scan I wasn’t told to be fasting, so I waited an additional 6 
hours’). During the treatment phase, experienced errors 
related to surgery, to chemotherapy, radiotherapy as well 
as other cancer specific clinical procedures. The patient 
experienced surgical errors included infections and wound 
problems (dehiscence/herniation) (‘a small part of the wound 
wouldn’t heal and developed into a deep wound. The plasti 
c surgeons had to perform revision surgery’). A few patients 
experienced medication errors in terms of wrong drug, 
dose, duration or timing. 
 
Other Errors 
Few patients only described a minor proportion of the 
errors. They were all pooled in the category ‘other errors’ 
(‘the doctor didn’t find out anything at all, so I had to demand a 
second opinion. Only then something happened’).  
 
Consequences of Errors 
Patients who experienced that hospital errors had 
consequences reported one or more of the following 
impacts: 1) organizational consequences as increased 
length of stay, readmission or prolongation of the patient 
journey (‘I had too much chemotherapy so I was admitted with 
diarrhea and was hospitalized for almost a month’), 2) physical 
consequences (‘My urethra was not sutured properly so urine and 
blood leaked into the abdominal cavity. It was so serious that I 
thought I would die’), 3) psychological consequences 
Table 2. Frequency of experienced consequences of errors during hospital treatment (n = number of responses) 
 
Consequences of error 
Question Yes No Do not know 
Q57 
If you experienced any errors, did the errors affect 
you (e.g. increased length of hospital stay, insecurity)? 
(n=451) 
275 (61%) 126 (28%) 50 (11%) 
 
 
Table 3. Frequency of experienced errors in relation to cancer diagnostics (n = number of responses) 
 
Question Yes No Don’t know 























Have you experienced one or more of the following types of errors at 
the hospital before you were diagnosed? 
Number of errors* 
(% of total number of errors) 
Q26a 
My treatment was delayed because the doctors thought I 
had some other disease than cancer 
168 (24%) 
Q26b 
The hospital did not call me in for examinations my 
GP/specialist practitioner had referred me to 
69 (10%) 
Q26c 
Test results were not available as expected (delayed or 
mislaid) 
146 (21%) 
Q26d My medical record was not available when needed 62 (9%) 
Q26e Other errors 256 (36%) 
Total number of experienced errors (Q26a-e) 701 (100%)* 
*The total number of experienced errors exceeds the number of patients who have experienced errors because each patient 
may experience more than one error. 
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(‘Insecurity, doubt – what would be the consequences? Especially my 
family was affected’) or 4) social consequences (‘I have not been 




Overall, 10-25% of the cancer patients experienced error. 
The prevalence was higher during treatment than 
diagnostics. Compared to other studies of patient 
experienced error the estimates are on a par.9,12 Compared 
to international health professional estimates of error, the 
prevalence is high.13-14 This may be because patients and 
healthcare professionals have different perspectives on 
errors.1,5,8 
 
Sample sizes vary across items in the questionnaire. This 
reflects certain selectivity in patient responses because no 
two patient journeys are quite alike. The questionnaire was 
designed to reflect a ‘standard journey’. Thus, it was 
expected that not all items were relevant to all patients and 
that sample sizes would vary from question to question. 
We do not know if the layout of the questionnaire 
contributes to the sample size variation but in the future, 
the survey will be developed into an electronic aadaptive 
questionnaire design. Hopefully, this will support the 




More than a quarter of those who experienced errors 
indicated that errors/complications occurred that they 
were not informed of prior to surgery. This reflects the 
problems summarized by the National Quality Forum 
almost a decade ago.15-17 Our data does not determine 
whether information was not provided or not perceived. 
Either way the findings call for a focus on practices 
concerning informed consent. 
 
Qualitative Analysis 
In relation to cancer detection about a quarter of those who 
experienced an error reported that their treatment was 
delayed because the doctors thought they suffered from 
some other disease than cancer. The described diagnostic 
errors revolve around this clinician assessment theme but 
also outline how symptoms were overlooked/not 
investigated and how examinations did not reveal the 
cancer or had to be repeated. Missed and delayed diagnosis 
of cancer is known to be common and harmful18-22 and 
can be attributed to factors related to both patients and 
providers e.g. patients not contacting the GP when 
 
Table 4. Frequency of experienced errors in relation to treatment (n = number of responses) 
 
Question Yes No 
Q 56 
Did you experience any errors at the hospital during treatment? 
(n=2,206) 
553 (25%) 1653 (75%) 
Sub question 
Have you experienced one or more of the following types of errors in 
connection with your hospital treatment? 
Number of errors* 
(% of total number of errors) 
Q56a 
Surgery  
Errors/complications occurred, the risk of which I had not been 





I was given wrong medication 10 (1%)* 
I was given a wrong dose of medicine 29 (4%)* 
I was given my chemotherapy with a delay or not at all 42 (5%)* 
I was given chemotherapy that ran outside the vein 16 (2%)* 
Q56c 
Radiation therapy  
I received radiation on a wrong part of the body 4 (1%)* 




Important information about my treatment (e.g. records and letters) 
were missing when I reported to a new ward/hospital 
70 (9%)* 
Test results were not available as expected (delayed or mislaid) 118 (15%)* 
Q56e Other errors 292 (36%)* 
Total number of experienced errors (Q56a-e) 807 (100%)* 
*The total number of experienced errors exceeds the number of patients who have experienced errors because each patient 
may experience more than one error. 
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experiencing cancer suspect symptoms or errors in clinical 
reasoning/cognitive errors. 20,22-25  
 
The safety challenges related to planning & coordination refer 
to delay in the patient journey. In 2007, standardised 
cancer patient pathways to ensure fast diagnosis of 
patients suspected of having cancer were introduced in 
Denmark in order to reduce waiting times from referral to 
treatment. The pathways have reduced waiting times and 
the improvement efforts are now expanded with the 
implementation of diagnostic centres for evaluation of 
patients with nonspecific, serious symptoms and with 'No-
Yes-Clinics' for cancer investigations when the patient 
presents with common symptoms. The initiatives all apply 
to the time until primary treatment, but will not affect the 
delay during or after treatment, which is described by 
some patients in this study. 
 
Other patient safety aspects related to patient-provider 
communication arise from the descriptions of doctors not 
listening to or taking patients seriously or from patients 
feeling rejected. This adds a new dimension to patient 
safety in the period from onset of symptoms to diagnosis. 
Safety aspects of patient-provider communication are not 
as well described in the literature as inter-professional 
communication, but it is well known that multiple factors 
affect patient-provider communication, e.g. time 
limitations, patient’s fear of cancer or of embarrassment.18-
20,26 Further studies of ’lack of listening’ and the doctors’ 
‘risk perception’ (probability of cancer) is needed. 
 
Of the experienced errors at hospital until time of 
diagnosis, more than a fifth addressed test results that were 
not made available as expected (delayed or mislaid). 
Administrative processes are not always visible to patients, but 
many patients in this study report on errors involving 
referrals, test results or the medical chart. The patients also 
describe how they often identify these errors themselves. 
Other studies demonstrate similar types of errors and 
suggest that systems improvement is needed.22,27,28 A 
fragmented health care system has an inherent risk of 
these administrative errors going unnoticed and patients 
may play a vital role in bridging these gaps. Despite their 
limited insight into the core processes of health care 
patients, at most stages of care, can contribute by speaking 
up when things do not seem right, e.g. when care plans are 
not followed, test results are not received etc. However, a 
prerequisite for this is that the patient is encouraged to 
participate, and the health care professionals are supported 
in and prepared for patient involvement.  
 
Patients also reported errors related to treatment & 
medication processes. As is the case with provider reported 
errors, these types of errors stimulate reflection on how to 
distinguish error from complication.1,29 Assessing 
preventability is key to differentiation, but is not an exact 
science and based on the relatively short descriptions in 
the survey pose a significant challenge.30 In this study no 
efforts were made to exclude experienced errors according 
to a distinction between error and complication.  
The consequences of error are not limited to physical injury. 
The patients’ psychological wellbeing as well as social 
function can also be affected. The reported organizational 
impact – e.g. increased length of stay – indicates the 
potential cost savings related to safety improvement but 
does not allow for quantification hereof.   
 
Methodological Limitations 
This study has some methodological limitations. First, the 
discovery that 67 patients described errors in the final 
generic comment box without stating these experiences in 
the error section of the questionnaire stresses the 
challenges of safety terminology. Due to the lack of a 
better alternative, the word ‘error’ was used in the 
questionnaire. The initial cognitive validation showed that 
the patients consider errors to be rather serious problems, 
and not – as one might speculate – more trivial issues. 
This was confirmed in the responses to the open-ended 
questions. Based on prior experience with provider 
reported safety issues apparently patients and providers to 
some extend share their understanding of the term error1. 
Nevertheless, both parties are in a position to identify 
errors that are invisible to the other part (e.g. providers 
more easily detect errors related to clinical and 
administrative processes, whereas patients more easily 
detect errors related to e.g. continuity of care).  
Unfortunately, the results of this study do not help us to 
refine our terminology prospectively. 
 
Second, one person carried out coding of types of errors 
only. This eliminates the challenges related to inter rater 
reliability, but at the expense of support to 
intersubjectivity. As the coder was an expert in patient 
safety, the approach introduced a bias according to the 
coder’s knowledge of existing error classifications. At the 
outset of the analysis, a co-author independently 
categorized a random sample of 250 responses. In order to 
minimize the ‘expert bias’ divergent coding was discussed 
by the two coders in an informal consensus process, (e.g. 
the understanding of waiting time as either an error or a 
consequences category was debated). Furthermore, the 
consensus process was used to explore and clarify the 
understanding of the various categories. 
 
Third, due to the numerous responses to open questions, 
this study provides detailed insight into patient’s 
perception of errors in the cancer journey. The 
descriptions complement the quantitative responses, thus 
provide details on ‘new’ types of error, causes, 
contributing factors or context. Since a survey does not 
allow for clarification if comments are imprecise or 
unclear, sometimes comments are difficult to understand 
and use. 
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Fourth, our study is disease specific with only cancer 
patients being included. The results reveal patient 
experienced errors that also appear in other patient 
populations. Despite the generic types of some errors the 
disease may be of importance, e.g. the prevalence of some 
types of errors may be higher in the complex cancer 
patient journey or the consequences may be more severe 
for cancer patients. This may affect generalization of the 
results. 
 
Our findings confirm that patients can supplement health 
care’s knowledge on patient safety issues. The results 
suggest that greater attention to the patient-provider 
communication is needed, with a specific focus on 
information on surgical complications. Also, measures 
aiming at mitigating administrative errors should be taken. 
The fact that patients identify errors that are not 
necessarily recognized by the health care system sets the 
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